Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study

Authors: Agarwal V
Agarwal V
Aggarwal R
Ajmani S
Asranna A
Barman B
Bartoloni Bocci E
Bommakanti KT
Cavagna L
Chandwar K
Chatterjee T
Chinoy H
Chowdhury AC
COVAD Study Group.
Danielli MG
Day J
De Angelis R
Del Papa N
Dey M
Distler O
Fabiola A
Franceschini F
Fusaro E
García-De La Torre I
Gheita T
Gil-Vila A
Gonzalez RA
Goswami RP
Govoni M
Gracia-Ramos AE
Gupta L
Gupta V
Hoff LS
Jain A
Joshi M
Kaneko Y
Kardes S
Kavadichanda CG
Kim M
Kimura N
Knitza J
Kusumo Wibowo SA
Kuwana M
Langguth D
Lilleker JB
Limaye V
Loarce-Martos J
Makol A
Manoj MM
Mathew AJ
Milchert M
Nakashima R
Needham M
Nikiphorou E
Nune A
Orsolini G
Pande AR
Pandya SC
Parisi S
Parodis I
Patro PS
Pauling JD
Phatak S
Pilania RK
Prieto-González S
Quartuccio L
R N
Ranjan R
Rojas Serrano J
Saavedra MA
Saha S
Sainaghi PP
Salim B
Sambataro G
Sato S
Sebastiani GD
Sebastiani M
Selva O'Callaghan A
Sen P
Sharma A
Shenoy P
Shinjo SK
Shukla A
Singh YP
Srivastav N
Tan AL
Tomaras S
Traboco LS
Velikova T
Venerito V
Wincup C
Yoshida A
Zamora Tehozol EA
Ziade N
Üsküdar Cansu D
Publication date: 1 January 2023
Publisher

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

IRIS UniversitÃ Politecnica delle Marche

redirect

oai

oai:iris.univpm.it:11566/31438...

Last time updated on 07/06/2023